Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Neuraminidase | 3 | 2018 | 289 | 1.73 | Why? |
| Influenza, Human | 15 | 2021 | 10779 | 0.83 | Why? |
| Influenza A Virus, H1N2 Subtype | 1 | 2018 | 19 | 0.75 | Why? |
| Influenza A Virus, H3N2 Subtype | 3 | 2018 | 572 | 0.73 | Why? |
| Sentinel Surveillance | 4 | 2020 | 1093 | 0.68 | Why? |
| Influenza B virus | 3 | 2018 | 815 | 0.66 | Why? |
| Enzyme Inhibitors | 2 | 2018 | 1881 | 0.66 | Why? |
| Drug Resistance, Viral | 3 | 2018 | 1083 | 0.65 | Why? |
| Reassortant Viruses | 1 | 2018 | 287 | 0.61 | Why? |
| Influenza Vaccines | 8 | 2021 | 2941 | 0.60 | Why? |
| Influenza A Virus, H1N1 Subtype | 4 | 2018 | 2984 | 0.60 | Why? |
| Respiratory Syncytial Virus, Human | 2 | 2021 | 846 | 0.60 | Why? |
| Netherlands | 12 | 2021 | 3533 | 0.58 | Why? |
| Orthomyxoviridae | 4 | 2021 | 1168 | 0.56 | Why? |
| Respiratory Syncytial Virus Infections | 2 | 2021 | 1234 | 0.50 | Why? |
| Influenza A virus | 4 | 2017 | 2234 | 0.47 | Why? |
| Seasons | 7 | 2021 | 4071 | 0.35 | Why? |
| Point-of-Care Testing | 1 | 2020 | 2782 | 0.32 | Why? |
| Inhibitory Concentration 50 | 2 | 2018 | 907 | 0.28 | Why? |
| Microbial Sensitivity Tests | 3 | 2018 | 2886 | 0.27 | Why? |
| Antiviral Agents | 4 | 2018 | 41703 | 0.22 | Why? |
| Clinical Laboratory Techniques | 4 | 2020 | 23402 | 0.21 | Why? |
| History, 21st Century | 3 | 2017 | 1849 | 0.21 | Why? |
| Amino Acid Substitution | 2 | 2018 | 1706 | 0.21 | Why? |
| Laboratories | 4 | 2021 | 2858 | 0.20 | Why? |
| RNA-Directed DNA Polymerase | 1 | 2020 | 170 | 0.20 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2020 | 13720 | 0.20 | Why? |
| Acids, Carbocyclic | 1 | 2017 | 27 | 0.18 | Why? |
| Artifacts | 1 | 2020 | 250 | 0.18 | Why? |
| Cyclopentanes | 1 | 2017 | 55 | 0.17 | Why? |
| Pyrans | 1 | 2017 | 56 | 0.17 | Why? |
| Zanamivir | 1 | 2017 | 63 | 0.17 | Why? |
| Viral Proteins | 1 | 2016 | 7370 | 0.17 | Why? |
| Coronavirus | 4 | 2020 | 18339 | 0.16 | Why? |
| Oseltamivir | 2 | 2018 | 583 | 0.16 | Why? |
| Hemofiltration | 1 | 2018 | 155 | 0.15 | Why? |
| Sialic Acids | 1 | 2017 | 218 | 0.15 | Why? |
| Infant | 7 | 2021 | 30274 | 0.14 | Why? |
| Epidemics | 3 | 2021 | 6407 | 0.13 | Why? |
| World Health Organization | 2 | 2017 | 4213 | 0.13 | Why? |
| Guanidines | 1 | 2017 | 499 | 0.12 | Why? |
| Mutation, Missense | 1 | 2018 | 863 | 0.12 | Why? |
| Molecular Sequence Data | 1 | 2018 | 3198 | 0.12 | Why? |
| Influenza in Birds | 1 | 2017 | 528 | 0.11 | Why? |
| Whole Genome Sequencing | 2 | 2020 | 3239 | 0.11 | Why? |
| Population Surveillance | 2 | 2019 | 4967 | 0.11 | Why? |
| Reagent Kits, Diagnostic | 1 | 2020 | 2149 | 0.10 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.10 | Why? |
| Nasal Mucosa | 1 | 2017 | 1218 | 0.10 | Why? |
| Sequence Analysis, DNA | 1 | 2018 | 2830 | 0.10 | Why? |
| Global Health | 3 | 2018 | 13911 | 0.10 | Why? |
| Age Distribution | 1 | 2019 | 3567 | 0.10 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.10 | Why? |
| Sensitivity and Specificity | 5 | 2021 | 22971 | 0.10 | Why? |
| Child, Preschool | 5 | 2019 | 36283 | 0.09 | Why? |
| Child | 9 | 2022 | 70012 | 0.09 | Why? |
| RNA Viruses | 1 | 2016 | 824 | 0.09 | Why? |
| Humans | 31 | 2022 | 930598 | 0.09 | Why? |
| Infant, Newborn | 3 | 2019 | 23105 | 0.09 | Why? |
| Community-Acquired Infections | 1 | 2020 | 2328 | 0.08 | Why? |
| Dose-Response Relationship, Drug | 1 | 2016 | 3776 | 0.08 | Why? |
| Case-Control Studies | 4 | 2021 | 17671 | 0.08 | Why? |
| Pyrazines | 1 | 2018 | 1783 | 0.08 | Why? |
| Europe | 5 | 2021 | 12702 | 0.08 | Why? |
| Amides | 1 | 2018 | 1864 | 0.08 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.08 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.08 | Why? |
| Immunoglobulin A | 1 | 2017 | 3567 | 0.07 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.07 | Why? |
| Adolescent | 7 | 2022 | 86841 | 0.07 | Why? |
| Molecular Diagnostic Techniques | 1 | 2021 | 4239 | 0.07 | Why? |
| Aerosols | 1 | 2021 | 5393 | 0.07 | Why? |
| Epidemiological Monitoring | 1 | 2017 | 3493 | 0.07 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.06 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.06 | Why? |
| Nasopharynx | 2 | 2020 | 10224 | 0.06 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.06 | Why? |
| Incidence | 3 | 2022 | 25622 | 0.06 | Why? |
| Phylogeny | 2 | 2020 | 13341 | 0.06 | Why? |
| Young Adult | 6 | 2019 | 93724 | 0.06 | Why? |
| Influenzavirus B | 1 | 2021 | 56 | 0.06 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 2 | 2021 | 8843 | 0.06 | Why? |
| Influenzavirus A | 1 | 2021 | 66 | 0.05 | Why? |
| Databases, Factual | 1 | 2016 | 6248 | 0.05 | Why? |
| Iceland | 1 | 2021 | 314 | 0.05 | Why? |
| Adult | 10 | 2022 | 244371 | 0.05 | Why? |
| Respiratory Tract Infections | 2 | 2021 | 6817 | 0.05 | Why? |
| Disease Transmission, Infectious | 2 | 2021 | 9044 | 0.05 | Why? |
| Female | 11 | 2021 | 380317 | 0.05 | Why? |
| Sneezing | 1 | 2021 | 173 | 0.05 | Why? |
| DNA Probes | 1 | 2020 | 178 | 0.05 | Why? |
| SARS Virus | 2 | 2021 | 13021 | 0.05 | Why? |
| Specimen Handling | 1 | 2017 | 6190 | 0.05 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
| Singing | 1 | 2021 | 143 | 0.05 | Why? |
| Aged | 7 | 2021 | 215776 | 0.04 | Why? |
| Virus Diseases | 1 | 2016 | 3779 | 0.04 | Why? |
| Genome, Viral | 1 | 2020 | 13157 | 0.04 | Why? |
| Sequence Analysis | 1 | 2020 | 496 | 0.04 | Why? |
| Nasal Lavage Fluid | 1 | 2017 | 43 | 0.04 | Why? |
| Middle Aged | 8 | 2019 | 270681 | 0.04 | Why? |
| Control Groups | 1 | 2017 | 49 | 0.04 | Why? |
| Male | 10 | 2021 | 367725 | 0.04 | Why? |
| Pathology, Molecular | 1 | 2020 | 343 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Aged, 80 and over | 4 | 2019 | 88759 | 0.04 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.04 | Why? |
| European Union | 1 | 2020 | 565 | 0.04 | Why? |
| Mutation | 1 | 2016 | 12376 | 0.04 | Why? |
| Reference Standards | 1 | 2020 | 1163 | 0.04 | Why? |
| Coinfection | 1 | 2016 | 6820 | 0.04 | Why? |
| DNA Primers | 1 | 2020 | 1170 | 0.04 | Why? |
| Protein Array Analysis | 1 | 2017 | 387 | 0.04 | Why? |
| Coronavirus NL63, Human | 1 | 2021 | 669 | 0.04 | Why? |
| Beijing | 1 | 2018 | 912 | 0.04 | Why? |
| Birds | 1 | 2017 | 412 | 0.03 | Why? |
| Immunity, Mucosal | 1 | 2017 | 426 | 0.03 | Why? |
| Coronavirus OC43, Human | 1 | 2021 | 1157 | 0.03 | Why? |
| Primary Health Care | 2 | 2021 | 4839 | 0.03 | Why? |
| Coronavirus 229E, Human | 1 | 2021 | 1241 | 0.03 | Why? |
| Air Microbiology | 1 | 2021 | 1322 | 0.03 | Why? |
| Family Characteristics | 1 | 2022 | 2551 | 0.03 | Why? |
| Independent Living | 1 | 2017 | 842 | 0.03 | Why? |
| Delayed Diagnosis | 1 | 2020 | 1529 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.02 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2017 | 1439 | 0.02 | Why? |
| Odds Ratio | 1 | 2021 | 5861 | 0.02 | Why? |
| Diagnostic Tests, Routine | 1 | 2020 | 2643 | 0.02 | Why? |
| Disease Susceptibility | 1 | 2022 | 4002 | 0.02 | Why? |
| Fatal Outcome | 1 | 2018 | 3438 | 0.02 | Why? |
| Viral Envelope Proteins | 1 | 2020 | 3539 | 0.02 | Why? |
| Disease Outbreaks | 3 | 2020 | 27595 | 0.02 | Why? |
| Cough | 1 | 2021 | 4891 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2020 | 3755 | 0.02 | Why? |
| Logistic Models | 1 | 2021 | 9089 | 0.02 | Why? |
| France | 1 | 2021 | 12074 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2017 | 51949 | 0.02 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.02 | Why? |
| Prospective Studies | 2 | 2020 | 43301 | 0.02 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.01 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 7868 | 0.01 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2018 | 8248 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.01 | Why? |
| Critical Illness | 1 | 2018 | 17281 | 0.01 | Why? |
| Intensive Care Units | 1 | 2018 | 29594 | 0.01 | Why? |
| Risk Factors | 1 | 2017 | 71621 | 0.01 | Why? |
| Animals | 1 | 2017 | 78931 | 0.01 | Why? |
Meijer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(150)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(195)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_